Skip to main content

Table 2 Study results

From: Vitamin D status in full-term exclusively breastfed infants versus full-term breastfed infants receiving vitamin D supplementation in Thailand: a randomized controlled trial

Characteristics

Exclusively breastfed without vitamin D supplementation (control group)

n = 44

Exclusively breastfed with vitamin D supplementation (intervention group)

n = 43

p-value

Mother

Vitamin D levels

  25OHD2, ng/mL

0.10 ± 0.38

0.08 ± 0.37

0.83

  25OHD3, ng/mL

24.97 ± 7.77

23.67 ± 7.70

0.44

  25OHD (total), ng/mL

25.08 ± 7.75

23.75 ± 7.64

0.42

Vitamin D (25OHD) status

  

0.25

  Deficiency, < 12 ng/mL

1 (2.3)

1 (2.3)

 

  Insufficiency, 12–20 ng/mL

9 (20.5)

15 (34.9)

 

  Sufficiency, > 20 ng/mL

34 (77.3)

27 (62.8)

 

Infant

Vitamin D levels

  25OHD2, ng/mL

0.00 ± 0.00

0.00 ± 0.00

  25OHD3, ng/mL

20.57 ± 12.66

46.01 ± 16.42

< 0.01

  25OHD (total), ng/mL

20.57 ± 12.66

46.01 ± 16.42

< 0.01

Vitamin D (25OHD) status

  

< 0.01

  Deficiency, < 12 ng/mL

11 (25.0)

0 (0.0)

 

  Insufficiency, 12–20 ng/mL

14 (31.8)

3 (7.0)

 

  Sufficiency, > 20 ng/mL

19 (43.2)

40 (93.0)

 

Serum bone markers

  Calcium, mg/dL

10.60 ± 0.37

10.57 ± 0.32

0.73

  Phosphorous, mg/dL

5.47 ± 0.45

5.53 ± 0.40

0.49

  ALP, U/L

250.41 ± 59.71

242.79 ± 58.54

0.54

  iPTH, pg/mL

19.45 (10.85–34.35)

16.3 (12.1–23.5)

0.13

Physical growth parameters

  Δ Weight, g

2059 ± 545

2087 ± 495

0.80

  Δ Length, cm

8.5 ± 1.4

8.6 ± 1.5

0.94

  Δ Head circumference, cm

4.0 ± 0.8

4.0 ± 1.0

0.70

  1. Data are presented as mean ± standard deviation, n (%), or median (interquartile range)
  2. Δ represents the increment in each parameter from 2 to 6 months
  3. 25OHD2 25-hydroxyvitamin D2, 25OHD3 25-hydroxyvitamin D3, 25OHD total 25-hydroxyvitamin D, ALP Alkaline phosphatase, iPTH Intact parathyroid hormone